Invention Application
- Patent Title: PRC2 INHIBITORS
-
Application No.: US17116270Application Date: 2020-12-09
-
Publication No.: US20210101904A1Publication Date: 2021-04-08
- Inventor: Matthew Arnold MARX , Matthew Randolph LEE , Thomas P. BOBINSKI , Aaron Craig BURNS , Nidhi ARORA , James Gail CHRISTENSEN , John Michael KETCHAM
- Applicant: Mirati Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Mirati Therapeutics, Inc.
- Current Assignee: Mirati Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
Public/Granted literature
- US11091495B2 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Public/Granted day:2021-08-17
Information query
